Recruiting Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas NCT06709495 Conditions Desmoplastic Small Round Cell Tumor, Myosarcoma, Neoplasms, +10 more Locations Boston Children's Hospital — Boston, Massachusetts, United States Dana-Farber Cancer Institute — Boston, Massachusetts, United States Brigham and Women's Hospital — Boston, Massachusetts, United States View Trial Details
Completed PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma NCT03139331 Conditions Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more Locations UCSF Benioff Children's Hospital, Oakland — Oakland, California, United States University of California, San Francisco — San Francisco, California, United States Dana-Farber Cancer Institute — Boston, Massachusetts, United States View Trial Details
